These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 26597283)

  • 1. What Is the Plural of a 'Yellow' Anecdote?
    Evans SJ
    Drug Saf; 2016 Jan; 39(1):1-3. PubMed ID: 26597283
    [No Abstract]   [Full Text] [Related]  

  • 2. Safety surveillance of longitudinal databases: further methodological considerations.
    Schuemie MJ
    Pharmacoepidemiol Drug Saf; 2012 Jun; 21(6):670-2; author reply 673-5. PubMed ID: 22678687
    [No Abstract]   [Full Text] [Related]  

  • 3. Safety surveillance of longitudinal databases: methodological considerations.
    Norén GN; Hopstadius J; Bate A; Edwards IR
    Pharmacoepidemiol Drug Saf; 2011 Jul; 20(7):714-7. PubMed ID: 21638520
    [No Abstract]   [Full Text] [Related]  

  • 4. Automatic detection of adverse events to predict drug label changes using text and data mining techniques.
    Gurulingappa H; Toldo L; Rajput AM; Kors JA; Taweel A; Tayrouz Y
    Pharmacoepidemiol Drug Saf; 2013 Nov; 22(11):1189-94. PubMed ID: 23935003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of adverse drug reactions using hospital databases-a nationwide study in Portugal.
    Miguel A; Bernardo Marques ; Freitas A; Lopes F; Azevedo L; Pereira AC
    Pharmacoepidemiol Drug Saf; 2013 Aug; 22(8):907-13. PubMed ID: 23761351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug safety: withdrawn medications are only part of the picture.
    Rawson NS
    BMC Med; 2016 Feb; 14():28. PubMed ID: 26873482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessing the extent and impact of the masking effect of disproportionality analyses on two spontaneous reporting systems databases.
    Maignen F; Hauben M; Hung E; Van Holle L; Dogne JM
    Pharmacoepidemiol Drug Saf; 2014 Feb; 23(2):195-207. PubMed ID: 24243665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exploration of statistical shrinkage parameters of disproportionality methods in spontaneous reporting system of China.
    Wang J; Ye XF; Guo XJ; Zhu TT; Qi N; Hou YF; Zhang TY; Shi WT; Wei X; Liu YZ; Wu GZ; He J
    Pharmacoepidemiol Drug Saf; 2015 Sep; 24(9):962-70. PubMed ID: 26095121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The 'power' of signal-detection algorithms.
    Karim MR; Klincewicz SL; Yee CL
    Drug Saf; 2008; 31(3):271-2, author reply 272-3. PubMed ID: 18302451
    [No Abstract]   [Full Text] [Related]  

  • 10. Methods for safety signal detection in healthcare databases: a literature review.
    Arnaud M; Bégaud B; Thurin N; Moore N; Pariente A; Salvo F
    Expert Opin Drug Saf; 2017 Jun; 16(6):721-732. PubMed ID: 28490262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of adverse drug reactions through the minimum basic data set.
    Salmerón-García A; Cabeza Barrera J; Vergara Pavón MJ; Román Márquez E; Cortés de Miguel S; Vallejo-Rodríguez I; Raya García S; Casado Fernández E
    Pharm World Sci; 2010 Jun; 32(3):322-8. PubMed ID: 20213432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pilot evaluation of an automated method to decrease false-positive signals induced by co-prescriptions in spontaneous reporting databases.
    Avillach P; Salvo F; Thiessard F; Miremont-Salamé G; Fourrier-Reglat A; Haramburu F; Bégaud B; Moore N; Pariente A;
    Pharmacoepidemiol Drug Saf; 2014 Feb; 23(2):186-94. PubMed ID: 23670805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Considerations for the analysis of longitudinal electronic health records linked to claims data to study the effectiveness and safety of drugs.
    Lin KJ; Schneeweiss S
    Clin Pharmacol Ther; 2016 Aug; 100(2):147-59. PubMed ID: 26916672
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Post-marketing withdrawal of 462 medicinal products because of adverse drug reactions: a systematic review of the world literature.
    Onakpoya IJ; Heneghan CJ; Aronson JK
    BMC Med; 2016 Feb; 14():10. PubMed ID: 26843061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Food and Drug Administration Adverse Event Reports of Retinal Vascular Occlusions Associated With Phosphodiesterase Type 5 Inhibitor Use.
    Li AS; Pomeranz HD
    J Neuroophthalmol; 2016 Dec; 36(4):480-481. PubMed ID: 27851718
    [No Abstract]   [Full Text] [Related]  

  • 16. [Drug-induced pancreatitis. A review of French spontaneous reports].
    Chebane L; Bagheri H; Hillaire-Buys D; Géniaux H; Yahioui N; Laroche ML; Cottin J; Spreux A; Mosquet B; Pecriaux C; Bellet F; Lambert A; Montastruc JL
    Rev Med Interne; 2015 Sep; 36(9):573-8. PubMed ID: 26045335
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An Empirical Approach to Explore the Relationship Between Measures of Disproportionate Reporting and Relative Risks from Analytical Studies.
    Maciá-Martínez MA; de Abajo FJ; Roberts G; Slattery J; Thakrar B; Wisniewski AF
    Drug Saf; 2016 Jan; 39(1):29-43. PubMed ID: 26507885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adverse reactions: know the risks.
    Shepherd M
    Nurs Times; 2011 Apr 5-11; 107(13):20. PubMed ID: 21678719
    [No Abstract]   [Full Text] [Related]  

  • 19. Triptans and serious adverse vascular events: data mining of the FDA Adverse Event Reporting System database.
    Roberto G; Piccinni C; D'Alessandro R; Poluzzi E
    Cephalalgia; 2014 Jan; 34(1):5-13. PubMed ID: 23921799
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Method for the Minimization of Competition Bias in Signal Detection from Spontaneous Reporting Databases.
    Arnaud M; Salvo F; Ahmed I; Robinson P; Moore N; Bégaud B; Tubert-Bitter P; Pariente A
    Drug Saf; 2016 Mar; 39(3):251-60. PubMed ID: 26715499
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.